Novel biological therapies for inflammatory bowel disease Pieter C. F. StokkersDaniel W. Hommes OriginalPaper Pages: 201 - 210
Colorectal cancer in inflammatory bowel disease: Molecular and clinical considerations David T. RubinNimisha Parekh OriginalPaper Pages: 211 - 220
Safety of biologics in inflammatory bowel disease Wojciech BlonskiGary R. Lichtenstein OriginalPaper Pages: 221 - 233
Management of refractory ulcerative colitis Sunana SohiRussell D. Cohen OriginalPaper Pages: 234 - 245
Adjuvant therapy for stage II colorectal cancer: Who and with what? Ki-Young Y. ChungDavid Kelsen OriginalPaper Pages: 272 - 280